DUBLIN, April 7, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Influenza Market - Vaccines and Therapeutics" report to their offering.
The global market for overall influenza is forecasts to reach a value of US$10.2 billion by 2022.
The influenza virus has been implicated in infecting millions of individuals on an annual basis, with vaccination programs against seasonal influenza infections necessitating the manufacture of hundreds of million doses within a very short time period. The emergence of innovative production systems based on mammalian or insect cell cultures have resulted in surmount the hurdles associated with the egg-based production system. These industrially well-established production systems provide a faster and more flexible response to pandemic threats.
This 128 page market research report includes 30 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 16 key global players and 39 major players across North America - 8; Europe - 10; Asia-Pacific - 20 and South & Central America - 1. The research also provides the listing of the companies engaged in research and development, manufacturing and supply of influenza vaccines and therapeutic. The global list of companies covers addresses, contact numbers and the website addresses of 80 companies.
- Abbott Laboratories
- Astrazeneca PLC
- Biocryst Pharmaceuticals, Inc.
- CSL Limited
- Daiichi Sankyo Co., Ltd.
- Glaxosmithkline PLC
- Hualan Biological Engineering Inc.
- Instituto Butantan
- Mitsubishi Tanabe Pharma Corporation
- Nanotherapeutics Inc.
- Protein Sciences Corporation
- Roche Holding AG
- Sanofi SA
- Shanghai Institute of Biological Products Co., Ltd.
- Shionogi & Co., Ltd.
- Sinovac Biotech Ltd.
Part A: Global Market Perspective
2. Major Products In Pipeline
3. Key Market Trends
4. Key Global Players
5. Key Business Trends
6. Global Market Overview
Part B: Regional Market Perspective Regional Market Overview 1. North America 2. Europe 3. Asia-Pacific 4. South & Central America 5. Middle East & Africa
Part C: Guide To The Industry
1. North America
4. Rest Of World
Part D: Annexure
1. Research Methodology
For more information visit http://www.researchandmarkets.com/research/flrdzm/global_influenza
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-influenza-market-value-of-usd-102-billion-by-2022---trends-technologies--opportunities-report-2016-2022---key-vendors-daiichi-sankyo-sanofi-roche---research-and-markets-300247745.html
SOURCE Research and Markets